| Literature DB >> 33974185 |
Hosam M Zowawi1,2,3, Adam D Irwin4,5, Abdulrahman K S Ayfan1,6, Joanne Macdonald7, Patrick N A Harris1,8, Claire Heney8, David L Paterson1, Ella Trembizki1, Claire Y T Wang9, David M Whiley1,8.
Abstract
Carbapenemase-producing organisms (CPOs) pose a serious clinical threat and rapid detection tools are essential to aid in patient management. We developed rapid and simple molecular tests to detect blaNDM-type and blaVIM-type carbapenemase genes using recombinase polymerase amplification (RPA) combined with a lateral flow detection. The tests could provide results in approximately 15 min when using DNA extracts, with limits of detection of 9.2 copies/μl for the blaNDM-type assay and 7.5 copies/μl for blaVIM-type assay, and successfully detected all isolates harbouring the carbapenemase encoding genes in a panel of 57 isolates. These RPA tests may be suitable for use in low-resource settings to tailor rapid implementation of infection control precautions and antibiotic stewardship.Entities:
Keywords: Carbapenemase; Lateral flow; NDM; Point-of-care; Recombinase polymerase amplification; VIM
Mesh:
Substances:
Year: 2021 PMID: 33974185 DOI: 10.1007/s10096-021-04267-6
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267